Bharat Immunologicals (India) Buy or Sell Recommendation

Macroaxis provides Bharat Immunologicals Biologicals Corp Ltd buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Bharat Immunologicals positions. The advice algorithm takes into account all of Bharat Immunologicals Biologicals Corp Ltd available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Bharat Immunologicals buy-and-hold prospective. Check also Bharat Immunologicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon

  

Risk Tolerance

  
Symbol
Execute Advice
Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 24.6  0.45  1.8%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bharat Immunologicals Biologicals Corp Ltd is 'Hold'.
For the selected time horizon Bharat Immunologicals Biologicals Corp Ltd has a risk adjusted performance of 0.0821, jensen alpha of 0.4244, total risk alpha of (1.82), sortino ratio of 0.1898 and treynor ratio of 0.6114
Macroaxis buy, hold, or sell recommendation module can be used to complement current analysts and expert consensus on Bharat Immunologicals. Our buy, hold, or sell suggestion engine makes use of analyzes the corporation potential to grow using all fundamental data market data available at the time. To make sure Bharat Immunologicals is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents .

Returns Distribution Density

Mean Return0.73Value At Risk3.54
Potential Upside3.5Standard Deviation4.77
 Return Density 
      Distribution 

Bharat Immunologicals Greeks

α
Alpha over DOW
=0.42
βBeta against DOW=1.19
σ
Overall volatility
=4.89
 IrInformation ratio =0.0987

Bharat Immunologicals Volatility Alert

Bharat Immunologicals Biologicals Corp Ltd currently demonstrates below average downside deviation of 2.48. It has Information Ratio of 0.1 and Jensen Alpha of 0.42. However, we do advice investors to further question Bharat Immunologicals Biologicals Corp Ltd expected returns to make sure all indicators are consistent with the current outlook about its relatively low value at risk.
    
 Better Than Average     
    
 Worse Than Average Compare Bharat Immunologicals to competition
FundamentalsBharat ImmunologicalsPeer Average
Return On Asset(1.69) % (15.64) %
Profit Margin(4.18) % (5.5) %
Operating Margin(5.13) % (10.91) %
Current Valuation862.5 M152.14 B
Shares Outstanding43.18 M1.43 B
Price to Earning(17.66) times40.69 times
Price to Book2.5 times14.44 times
Price to Sales0.66 times17.81 times
Revenue1.28 B9.85 B
Gross Profit119 M21.75 B
EBITDA(56.51 M)1.41 B
Net Income(53.46 M)517.71 M
Cash and Equivalents152.27 M3.89 B
Cash per Share3.55 times5.17 times
Total Debt177.56 M7.36 B
Debt to Equity0.5 % 0.72 %
Current Ratio1.69 times3.3 times
Earnings Per Share(1.24) times2.3 times
Number of Employees510.67 K
Market Capitalization971.55 M29.78 B
Z Score3.0708.73
SellBuy
Hold

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Currently Unavailable

Financial Leverage

Inapplicable
Risk Adjusted Performance0.0821
Market Risk Adjusted Performance0.6214
Mean Deviation2.67
Semi Deviation1.96
Downside Deviation2.48
Coefficient Of Variation649.92
Standard Deviation4.77
Variance22.8
Information Ratio0.0987
Jensen Alpha0.4244
Total Risk Alpha(1.82)
Sortino Ratio0.1898
Treynor Ratio0.6114
Maximum Drawdown23.77
Value At Risk(3.54)
Potential Upside3.5
Downside Variance6.17
Semi Variance3.85
Expected Short fall(3.65)
Skewness3.25
Kurtosis13.18